Specific blockade of spasmogens by beta-receptor stimulation with nylidrin and isoprenaline.
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000318:Adrenergic beta-Agonists; D000818:Animals; D001464:Barium / Q000037:antagonists & inhibitors; D001980:Bronchi / Q000187:drug effects; D001993:Bronchodilator Agents / Q000494:pharmacology; D006168:Guinea Pigs; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology*; D008297:Male; D009130:Muscle, Smooth / Q000187:drug effects; D011433:Propranolol / Q000494:pharmacology; D013566:Sympathomimetics / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology
D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D006634:Histamine H1 Antagonists; D013566:Sympathomimetics; D014665:Vasodilator Agents; D001464:Barium; D011433:Propranolol; D007545:Isoproterenol; D000109:Acetylcholine